Benjamin G. Jackson
General Counsel
Myriad Genetics Inc (MYGN)General Counsel
Sera Prognostics, Inc. (SERA)Equibles does not estimate personal net worth.
Get an email with a short summary when Myriad Genetics Inc publishes a filing, an earnings call transcript or a press release.
Get MYGN alertsAbout Benjamin G. Jackson
Benjamin G. Jackson is recorded as General Counsel at Myriad Genetics Inc (MYGN) and General Counsel at Sera Prognostics, Inc. (SERA). The newest filing on record that lists Benjamin G. Jackson as General Counsel at Myriad Genetics Inc (MYGN) is dated October 15, 2020. The newest filing on record that lists Benjamin G. Jackson as General Counsel at Sera Prognostics, Inc. (SERA) is dated April 24, 2026. The proxy statement of Sera Prognostics, Inc. reports total compensation of $1,617,971 for Benjamin G. Jackson in fiscal 2021, including a base salary of $223,260. Myriad Genetics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Sera Prognostics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Myriad Genetics Inc includes R. Bryan Riggsbee (CEO), R. Bryan Riggsbee Chief (CEO), Sam Raha (CEO and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed October 15, 2020
-
Current
Start not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at Myriad Genetics Inc
- R. Bryan Riggsbee CEO
- R. Bryan Riggsbee Chief CEO
- Sam Raha CEO, Board Member
- Samraat Raha CEO, COO, Board Member
- Samraat S. Raha CEO, Board Member
- Ben R. Wheeler CFO
- Benjamin R. Wheeler CFO
- Bryan Riggsbee CFO
- Scott Leffler CFO
- Mark S. Verratti COO
Leadership on record at Sera Prognostics, Inc.
- Zhenya Lindgardt CEO, Board Member
- Kim Kamdar, Ph.D. Chairman
- Austin Aerts CFO
- Scott Gleason CFO
- Robert G. Harrison CIO
- Continuing Directors Board Member
- Evguenia (Zhenya) Lindgardt Board Member
- Gregory Critchfield Board Member
- Jane F. Barlow Board Member
- Jane F. Barlow, M.D., MPH, MBA Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Sera Prognostics, Inc. (SERA) | General Counsel Represents the aggregate grant date fair value of option awards granted in the applicable fiscal year. Grant date fair value is calculated in accordance with Accounting Standards Codification ("ASC") Topic 718 ("ASC 718") issued by the Financial Accounting Standards Board. For the assumptions relating to valuations of equity awards made to our named executive officers, see Note 11 to our audited financial statements, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on March 29, 2022. Consists of bonus payments received under our non-equity incentive compensation plans based upon satisfaction of performance goals. See "Executive Compensation — Non-Equity Incentive Compensation Plan." Mr. Harrison and Mr. Jackson both began their employment with Sera Prognostics in 2021. | $223,260 | $1,617,971 |
Recent activity
No call appearances or filed executive changes recorded yet.